
Pharmaceutical Excipients Market Trends, Growth, Size By 2034
Pharmaceutical Excipients Market Growth, Size, Trends Analysis - By Product, By Functionality, By Formulation - Regional Outlook, Competitive Strategies and Segment Forecast to 2034
Published: Jun-2019 | Report ID: PHAR1911 | Pages: 1 - 107 | Formats*: |
Category : Pharmaceutical |


- Clariant, a speciality chemicals firm focussing on sustainability, announced a portfolio of high-performing pharmaceutical ingredient solutions in October 2023 to help advance the development of safe and effective medications. Clariant Health Care also increased its functional excipient portfolio to address active pharmaceutical ingredient (API) distribution and bioavailability concerns.
- In September 2023, Roquette, a firm that specialises in plant-based components and supplies pharmaceutical and nutraceutical excipients, introduced three new excipient grades to its line of solutions for active pharmaceutical and nutraceutical compounds that are sensitive to moisture.
Report Metric | Details |
Market size available for years | 2021-2034 |
Base year considered | 2024 |
Forecast period | 2025-2034 |
Segments covered | By Product, By Functionality, By Formulation |
Regions covered | North America, Latin America, Asia-Pacific, Europe, and Middle East & Africa |
Companies Covered | Air Liquide S.A, Archer Daniels Midland Company, Ashland, Associated British Foods PLC, BASF SE, Croda International PLC, Evonik Industries AG, Innophos, Kerry Group plc, Merck KGaA. |
- Global Pharmaceutical Excipients Market Size (FY’2021-FY’2034)
- Overview of Global Pharmaceutical Excipients Market
- Segmentation of Global Pharmaceutical Excipients Market By Product (Organic chemicals, Inorganic chemicals)
- Segmentation of Global Pharmaceutical Excipients Market By Functionality (Binder, Suspension and viscosity agents, Glidants, Preservatives, Filler & diluent, Lubricant, Emulsifier, Disintegrant, Other functionalities)
- Segmentation of Global Pharmaceutical Excipients Market By Formulation (Oral, Liquid, Parenteral, Topical, Other Formulations)
- Statistical Snap of Global Pharmaceutical Excipients Market
- Expansion Analysis of Global Pharmaceutical Excipients Market
- Problems and Obstacles in Global Pharmaceutical Excipients Market
- Competitive Landscape in the Global Pharmaceutical Excipients Market
- Details on Current Investment in Global Pharmaceutical Excipients Market
- Competitive Analysis of Global Pharmaceutical Excipients Market
- Prominent Players in the Global Pharmaceutical Excipients Market
- SWOT Analysis of Global Pharmaceutical Excipients Market
- Global Pharmaceutical Excipients Market Future Outlook and Projections (FY’2025-FY’2034)
- Recommendations from Analyst
- 1.1. Scope of the report
- 1.2. Market segment analysis
- 2.1. Research data source
- 2.1.1. Secondary Data
- 2.1.2. Primary Data
- 2.1.3. SPER’s internal database
- 2.1.4. Premium insight from KOL’s
- 2.2. Market size estimation
- 2.2.1. Top-down and Bottom-up approach
- 2.3. Data triangulation
- 4.1. Driver, Restraint, Opportunity and Challenges analysis
- 4.1.1. Drivers
- 4.1.2. Restraints
- 4.1.3. Opportunities
- 4.1.4. Challenges
- 5.1. SWOT Analysis
- 5.1.1. Strengths
- 5.1.2. Weaknesses
- 5.1.3. Opportunities
- 5.1.4. Threats
- 5.2. PESTEL Analysis
- 5.2.1. Political Landscape
- 5.2.2. Economic Landscape
- 5.2.3. Social Landscape
- 5.2.4. Technological Landscape
- 5.2.5. Environmental Landscape
- 5.2.6. Legal Landscape
- 5.3. PORTER’s Five Forces
- 5.3.1. Bargaining power of suppliers
- 5.3.2. Bargaining power of buyers
- 5.3.3. Threat of Substitute
- 5.3.4. Threat of new entrant
- 5.3.5. Competitive rivalry
- 5.4. Heat Map Analysis
- 6.1. Global Pharmaceutical Excipients Market Manufacturing Base Distribution, Sales Area, Product Type
- 6.2. Mergers & Acquisitions, Partnerships, Product Launch, and Collaboration in Global Pharmaceutical Excipients Market
- 7.1. Organic chemicals
- 7.1.1. Oleochemicals
- 7.1.2. Carbohydrates
- 7.1.3. Petrochemicals
- 7.1.4. Proteins
- 7.1.5. Other organic chemicals
- 7.2. Inorganic chemicals
- 7.2.1. Calcium phosphate
- 7.2.2. Metal oxides
- 7.2.3. Halites
- 7.2.4. Calcium carbonate
- 7.2.5. Calcium sulfate
- 7.2.6. Other inorganic chemicals
- 8.1. Binder
- 8.2. Suspension and viscosity agents
- 8.3. Glidants
- 8.4. Preservatives
- 8.5. Filler & diluent
- 8.6. Lubricant
- 8.7. Emulsifier
- 8.8. Disintegrant
- 8.9. Other functionalities
- 9.1. Oral
- 9.1.1. Tablet
- 9.1.2. Capsule
- 9.1.3. Other oral formulations
- 9.2. Liquid
- 9.3. Parenteral
- 9.4. Topical
- 9.5. Other formulations
- 10.1. Global Pharmaceutical Excipients Market Size and Market Share
- 11.1. Asia-Pacific
- 11.1.1. Australia
- 11.1.2. China
- 11.1.3. India
- 11.1.4. Japan
- 11.1.5. South Korea
- 11.1.6. Rest of Asia-Pacific
- 11.2. Europe
- 11.2.1. France
- 11.2.2. Germany
- 11.2.3. Italy
- 11.2.4. Spain
- 11.2.5. United Kingdom
- 11.2.6. Rest of Europe
- 11.3. Middle East and Africa
- 11.3.1. Kingdom of Saudi Arabia
- 11.3.2. United Arab Emirates
- 11.3.3. Qatar
- 11.3.4. South Africa
- 11.3.5. Egypt
- 11.3.6. Morocco
- 11.3.7. Nigeria
- 11.3.8. Rest of Middle-East and Africa
- 11.4. North America
- 11.4.1. Canada
- 11.4.2. Mexico
- 11.4.3. United States
- 11.5. Latin America
- 11.5.1. Argentina
- 11.5.2. Brazil
- 11.5.3. Rest of Latin America
- 12.1. Air Liquide S.A
- 12.1.1. Company details
- 12.1.2. Financial outlook
- 12.1.3. Product summary
- 12.1.4. Recent developments
- 12.2. Archer Daniels Midland Company
- 12.2.1. Company details
- 12.2.2. Financial outlook
- 12.2.3. Product summary
- 12.2.4. Recent developments
- 12.3. Ashland
- 12.3.1. Company details
- 12.3.2. Financial outlook
- 12.3.3. Product summary
- 12.3.4. Recent developments
- 12.4. Associated British Foods PLC
- 12.4.1. Company details
- 12.4.2. Financial outlook
- 12.4.3. Product summary
- 12.4.4. Recent developments
- 12.5. BASF SE
- 12.5.1. Company details
- 12.5.2. Financial outlook
- 12.5.3. Product summary
- 12.5.4. Recent developments
- 12.6. Croda International PLC
- 12.6.1. Company details
- 12.6.2. Financial outlook
- 12.6.3. Product summary
- 12.6.4. Recent developments
- 12.7. Evonik Industries AG
- 12.7.1. Company details
- 12.7.2. Financial outlook
- 12.7.3. Product summary
- 12.7.4. Recent developments
- 12.8. Innophos
- 12.8.1. Company details
- 12.8.2. Financial outlook
- 12.8.3. Product summary
- 12.8.4. Recent developments
- 12.9. Kerry Group plc
- 12.9.1. Company details
- 12.9.2. Financial outlook
- 12.9.3. Product summary
- 12.9.4. Recent developments
- 12.10. Merck KGaA
- 12.10.1. Company details
- 12.10.2. Financial outlook
- 12.10.3. Product summary
- 12.10.4. Recent developments
- 12.11. Others
SPER Market Research’s methodology uses great emphasis on primary research to ensure that the market intelligence insights are up to date, reliable and accurate. Primary interviews are done with players involved in each phase of a supply chain to analyze the market forecasting. The secondary research method is used to help you fully understand how the future markets and the spending patterns look likes.
The report is based on in-depth qualitative and quantitative analysis of the Product Market. The quantitative analysis involves the application of various projection and sampling techniques. The qualitative analysis involves primary interviews, surveys, and vendor briefings. The data gathered as a result of these processes are validated through experts opinion. Our research methodology entails an ideal mixture of primary and secondary initiatives.
Frequently Asked Questions About This Report
PLACE AN ORDER
Year End Discount
Sample Report
Pre-Purchase Inquiry
NEED CUSTOMIZATION?
Request CustomizationCALL OR EMAIL US
100% Secure Payment






Related Reports
Our Global Clients
Our data-driven insights have influenced the strategy of 200+ reputed companies across the globe.